Advertisement

Index by author

February 01, 1999; Volume 55,Issue 2

A

  1. Abuin, Liliane

    1. Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
      Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
      Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339

  2. Albano, Emanuele

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  3. Anizon, Fabrice

    1. Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue
      Christian Bailly, Xiaogang Qu, Fabrice Anizon, Michelle Prudhomme, Jean-François Riou and Jonathan B. Chaires
      Molecular Pharmacology February 1999, 55 (2) 377-385; DOI: https://doi.org/10.1124/mol.55.2.377

  4. Aricò, Sarino

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  5. Assreuy, Jamil

    1. Inhibition of Glucocorticoid Receptor Binding by Nitric Oxide
      Mario D. Galigniana, Graciela Piwien-Pilipuk and Jamil Assreuy
      Molecular Pharmacology February 1999, 55 (2) 317-323; DOI: https://doi.org/10.1124/mol.55.2.317

B

  1. Baenziger, John E.

    1. A Structure-Based Approach to Nicotinic Receptor Pharmacology
      Stephen E. Ryan and John E. Baenziger
      Molecular Pharmacology February 1999, 55 (2) 348-355; DOI: https://doi.org/10.1124/mol.55.2.348

  2. Bahia, Daljit S.

    1. Modulation of Relative Intrinsic Activity of Agonists at theAlpha-2A Adrenoceptor by Mutation of Residue 351 of G Protein Gi1α
      Vicky N. Jackson, Daljit S. Bahia and Graeme Milligan
      Molecular Pharmacology February 1999, 55 (2) 195-201; DOI: https://doi.org/10.1124/mol.55.2.195

  3. Bailly, Christian

    1. Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue
      Christian Bailly, Xiaogang Qu, Fabrice Anizon, Michelle Prudhomme, Jean-François Riou and Jonathan B. Chaires
      Molecular Pharmacology February 1999, 55 (2) 377-385; DOI: https://doi.org/10.1124/mol.55.2.377

  4. Barak, Larry S.

    1. Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
      Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
      Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339

  5. Barry, Peter H.

    1. The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating
      Andrew J. Moorhouse, Patrice Jacques, Peter H. Barry and Peter R. Schofield
      Molecular Pharmacology February 1999, 55 (2) 386-395; DOI: https://doi.org/10.1124/mol.55.2.386

  6. Beck, William T.

    1. DNA Damage Signals Induction of Fas Ligand in Tumor Cells
      Yin-Yuan Mo and William T. Beck
      Molecular Pharmacology February 1999, 55 (2) 216-222; DOI: https://doi.org/10.1124/mol.55.2.216

  7. Berts, Alf

    1. No Role for Ca++ or Protein Kinase C inAlpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells
      Alf Berts, Hongying Zhong and Kenneth P. Minneman
      Molecular Pharmacology February 1999, 55 (2) 296-303; DOI: https://doi.org/10.1124/mol.55.2.296

  8. Blanton, Michael P.

    1. The Steroid Promegestone Is a Noncompetitive Antagonist of theTorpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface
      Michael P. Blanton, Yu Xie, Lawrence J. Dangott and Jonathan. B. Cohen
      Molecular Pharmacology February 1999, 55 (2) 269-278; DOI: https://doi.org/10.1124/mol.55.2.269

  9. Bordone, Roberta

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  10. Botto, Jean-Marie

    1. Pivotal Role of an Aspartate Residue in Sodium Sensitivity and Coupling to G Proteins of Neurotensin Receptors
      Stéphane Martin, Jean-Marie Botto, Jean-Pierre Vincent and Jean Mazella
      Molecular Pharmacology February 1999, 55 (2) 210-215; DOI: https://doi.org/10.1124/mol.55.2.210

  11. Bouck, Noël P.

    1. Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
      David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
      Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332

  12. Bühling, Frank

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

  13. Butour, Jean-Luc

    1. Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
      Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
      Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324

C

  1. Cambois, Gilles

    1. Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
      Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
      Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324

  2. Capdevila, Jorge H.

    1. Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids
      Jianyong Chen, Jorge H. Capdevila, Darryl C. Zeldin and Robert L. Rosenberg
      Molecular Pharmacology February 1999, 55 (2) 288-295; DOI: https://doi.org/10.1124/mol.55.2.288

  3. Caron, Marc G.

    1. Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
      Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
      Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339

  4. Carr, Kenneth D.

    1. Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
      Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
      Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202

  5. Chaires, Jonathan B.

    1. Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue
      Christian Bailly, Xiaogang Qu, Fabrice Anizon, Michelle Prudhomme, Jean-François Riou and Jonathan B. Chaires
      Molecular Pharmacology February 1999, 55 (2) 377-385; DOI: https://doi.org/10.1124/mol.55.2.377

  6. Chen, Jianyong

    1. Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids
      Jianyong Chen, Jorge H. Capdevila, Darryl C. Zeldin and Robert L. Rosenberg
      Molecular Pharmacology February 1999, 55 (2) 288-295; DOI: https://doi.org/10.1124/mol.55.2.288

  7. Cohen, Jonathan. B.

    1. The Steroid Promegestone Is a Noncompetitive Antagonist of theTorpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface
      Michael P. Blanton, Yu Xie, Lawrence J. Dangott and Jonathan. B. Cohen
      Molecular Pharmacology February 1999, 55 (2) 269-278; DOI: https://doi.org/10.1124/mol.55.2.269

  8. Cotecchia, Susanna

    1. Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
      Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
      Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339

D

  1. Dangott, Lawrence J.

    1. The Steroid Promegestone Is a Noncompetitive Antagonist of theTorpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface
      Michael P. Blanton, Yu Xie, Lawrence J. Dangott and Jonathan. B. Cohen
      Molecular Pharmacology February 1999, 55 (2) 269-278; DOI: https://doi.org/10.1124/mol.55.2.269

  2. Dawson, David W.

    1. Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
      David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
      Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332

  3. Dean, Nicholas M.

    1. Induction of p53-Dependent, Insulin-Like Growth Factor-Binding Protein-3-Mediated Apoptosis in Glioblastoma Multiforme Cells by a Protein Kinase Cα Antisense Oligonucleotide
      Li Shen, Nicholas M. Dean and Robert I. Glazer
      Molecular Pharmacology February 1999, 55 (2) 396-402; DOI: https://doi.org/10.1124/mol.55.2.396

  4. Diviani, Dario

    1. Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
      Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
      Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339

E

  1. Elgoyhen, A. Belén

    1. The α9 Nicotinic Acetylcholine Receptor Shares Pharmacological Properties with Type A γ-Aminobutyric Acid, Glycine, and Type 3 Serotonin Receptors
      Carla V. Rothlin, Eleonora Katz, Miguel Verbitsky and A. Belén Elgoyhen
      Molecular Pharmacology February 1999, 55 (2) 248-254; DOI: https://doi.org/10.1124/mol.55.2.248

  2. Enyeart, John J.

    1. Purine and Pyrimidine Nucleotides Inhibit a Noninactivating K+ Current and Depolarize Adrenal Cortical Cells through a G Protein-Coupled Receptor
      Lin Xu and John J. Enyeart
      Molecular Pharmacology February 1999, 55 (2) 364-376; DOI: https://doi.org/10.1124/mol.55.2.364

F

  1. Feinstein, D. L.

    1. Inhibition of Astroglial Nitric Oxide Synthase Type 2 Expression by Idazoxan
      D. L. Feinstein, D. J. Reis and S. Regunathan
      Molecular Pharmacology February 1999, 55 (2) 304-308; DOI: https://doi.org/10.1124/mol.55.2.304

  2. Fraser, David J.

    1. Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
      David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
      Molecular Pharmacology February 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241

  3. French, Samuel W.

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  4. Fukuhara, Morio

    1. A Novel Positive Regulatory Element That Enhances HamsterCYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element
      Kouichi Kurose, Masahiro Tohkin and Morio Fukuhara
      Molecular Pharmacology February 1999, 55 (2) 279-287; DOI: https://doi.org/10.1124/mol.55.2.279

G

  1. Galigniana, Mario D.

    1. Inhibition of Glucocorticoid Receptor Binding by Nitric Oxide
      Mario D. Galigniana, Graciela Piwien-Pilipuk and Jamil Assreuy
      Molecular Pharmacology February 1999, 55 (2) 317-323; DOI: https://doi.org/10.1124/mol.55.2.317

  2. Garcia-Espana, Antonio

    1. Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
      Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
      Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202

  3. Gerhardt, C. C.

    1. Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation
      C. C. Gerhardt, J. Gros, A. D. Strosberg and T. Issad
      Molecular Pharmacology February 1999, 55 (2) 255-262; DOI: https://doi.org/10.1124/mol.55.2.255

  4. Giacomini, Kathleen M.

    1. Characterization of a Bioengineered Chimeric Na+-Nucleoside Transporter
      Juan Wang and Kathleen M. Giacomini
      Molecular Pharmacology February 1999, 55 (2) 234-240; DOI: https://doi.org/10.1124/mol.55.2.234

  5. Glazer, Robert I.

    1. Induction of p53-Dependent, Insulin-Like Growth Factor-Binding Protein-3-Mediated Apoptosis in Glioblastoma Multiforme Cells by a Protein Kinase Cα Antisense Oligonucleotide
      Li Shen, Nicholas M. Dean and Robert I. Glazer
      Molecular Pharmacology February 1999, 55 (2) 396-402; DOI: https://doi.org/10.1124/mol.55.2.396

  6. Goldstein, Menek

    1. Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
      Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
      Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202

  7. Gros, J.

    1. Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation
      C. C. Gerhardt, J. Gros, A. D. Strosberg and T. Issad
      Molecular Pharmacology February 1999, 55 (2) 255-262; DOI: https://doi.org/10.1124/mol.55.2.255

H

  1. Halpert, James R.

    1. Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
      David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
      Molecular Pharmacology February 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241

  2. Harlow, Greg R.

    1. Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
      David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
      Molecular Pharmacology February 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241

  3. Haycock, John W.

    1. Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
      Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
      Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202

  4. He, You Qun

    1. Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
      David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
      Molecular Pharmacology February 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241

  5. Helander, Anders

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  6. Henkin, Jack

    1. Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
      David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
      Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332

  7. Hidaka, Hiroyoshi

    1. Isolation of cDNAs Encoding Cellular Drug-Binding Proteins Using a Novel Expression Cloning Procedure: Drug-Western
      Hideki Tanaka, Nobuko Ohshima and Hiroyoshi Hidaka
      Molecular Pharmacology February 1999, 55 (2) 356-363; DOI: https://doi.org/10.1124/mol.55.2.356

  8. Höllt, Volker

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

I

  1. Ingelman-Sundberg, Magnus

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  2. Issad, T.

    1. Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation
      C. C. Gerhardt, J. Gros, A. D. Strosberg and T. Issad
      Molecular Pharmacology February 1999, 55 (2) 255-262; DOI: https://doi.org/10.1124/mol.55.2.255

J

  1. Jackson, Vicky N.

    1. Modulation of Relative Intrinsic Activity of Agonists at theAlpha-2A Adrenoceptor by Mutation of Residue 351 of G Protein Gi1α
      Vicky N. Jackson, Daljit S. Bahia and Graeme Milligan
      Molecular Pharmacology February 1999, 55 (2) 195-201; DOI: https://doi.org/10.1124/mol.55.2.195

  2. Jacques, Patrice

    1. The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating
      Andrew J. Moorhouse, Patrice Jacques, Peter H. Barry and Peter R. Schofield
      Molecular Pharmacology February 1999, 55 (2) 386-395; DOI: https://doi.org/10.1124/mol.55.2.386

K

  1. Katz, Eleonora

    1. The α9 Nicotinic Acetylcholine Receptor Shares Pharmacological Properties with Type A γ-Aminobutyric Acid, Glycine, and Type 3 Serotonin Receptors
      Carla V. Rothlin, Eleonora Katz, Miguel Verbitsky and A. Belén Elgoyhen
      Molecular Pharmacology February 1999, 55 (2) 248-254; DOI: https://doi.org/10.1124/mol.55.2.248

  2. Klutzny, Marcus

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

  3. Koch, Thomas

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

  4. Kurose, Kouichi

    1. A Novel Positive Regulatory Element That Enhances HamsterCYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element
      Kouichi Kurose, Masahiro Tohkin and Morio Fukuhara
      Molecular Pharmacology February 1999, 55 (2) 279-287; DOI: https://doi.org/10.1124/mol.55.2.279

L

  1. Lapalu, Sophie

    1. Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
      Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
      Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324

  2. Lee, Kwan Y.

    1. Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
      Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
      Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202

  3. Lew, Jow Y.

    1. Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
      Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
      Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202

  4. Lytton, Simon D.

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

M

  1. Martin, Stéphane

    1. Pivotal Role of an Aspartate Residue in Sodium Sensitivity and Coupling to G Proteins of Neurotensin Receptors
      Stéphane Martin, Jean-Marie Botto, Jean-Pierre Vincent and Jean Mazella
      Molecular Pharmacology February 1999, 55 (2) 210-215; DOI: https://doi.org/10.1124/mol.55.2.210

  2. Mazella, Jean

    1. Pivotal Role of an Aspartate Residue in Sodium Sensitivity and Coupling to G Proteins of Neurotensin Receptors
      Stéphane Martin, Jean-Marie Botto, Jean-Pierre Vincent and Jean Mazella
      Molecular Pharmacology February 1999, 55 (2) 210-215; DOI: https://doi.org/10.1124/mol.55.2.210

  3. Meller, Emanuel

    1. Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
      Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
      Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202

  4. Meunier, Jean-Claude

    1. Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
      Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
      Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324

  5. Mhaouty-Kodja, Sakina

    1. Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
      Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
      Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339

  6. Milligan, Graeme

    1. Modulation of Relative Intrinsic Activity of Agonists at theAlpha-2A Adrenoceptor by Mutation of Residue 351 of G Protein Gi1α
      Vicky N. Jackson, Daljit S. Bahia and Graeme Milligan
      Molecular Pharmacology February 1999, 55 (2) 195-201; DOI: https://doi.org/10.1124/mol.55.2.195

  7. Minneman, Kenneth P.

    1. No Role for Ca++ or Protein Kinase C inAlpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells
      Alf Berts, Hongying Zhong and Kenneth P. Minneman
      Molecular Pharmacology February 1999, 55 (2) 296-303; DOI: https://doi.org/10.1124/mol.55.2.296

  8. Mo, Yin-Yuan

    1. DNA Damage Signals Induction of Fas Ligand in Tumor Cells
      Yin-Yuan Mo and William T. Beck
      Molecular Pharmacology February 1999, 55 (2) 216-222; DOI: https://doi.org/10.1124/mol.55.2.216

  9. Moisand, Christiane

    1. Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
      Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
      Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324

  10. Mollereau, Catherine

    1. Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
      Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
      Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324

  11. Moorhouse, Andrew J.

    1. The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating
      Andrew J. Moorhouse, Patrice Jacques, Peter H. Barry and Peter R. Schofield
      Molecular Pharmacology February 1999, 55 (2) 386-395; DOI: https://doi.org/10.1124/mol.55.2.386

  12. Mouledous, Lionel

    1. Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
      Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
      Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324

O

  1. Ohshima, Nobuko

    1. Isolation of cDNAs Encoding Cellular Drug-Binding Proteins Using a Novel Expression Cloning Procedure: Drug-Western
      Hideki Tanaka, Nobuko Ohshima and Hiroyoshi Hidaka
      Molecular Pharmacology February 1999, 55 (2) 356-363; DOI: https://doi.org/10.1124/mol.55.2.356

P

  1. Pearce, S. Frieda A.

    1. Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
      David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
      Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332

  2. Piwien-Pilipuk, Graciela

    1. Inhibition of Glucocorticoid Receptor Binding by Nitric Oxide
      Mario D. Galigniana, Graciela Piwien-Pilipuk and Jamil Assreuy
      Molecular Pharmacology February 1999, 55 (2) 317-323; DOI: https://doi.org/10.1124/mol.55.2.317

  3. Prudhomme, Michelle

    1. Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue
      Christian Bailly, Xiaogang Qu, Fabrice Anizon, Michelle Prudhomme, Jean-François Riou and Jonathan B. Chaires
      Molecular Pharmacology February 1999, 55 (2) 377-385; DOI: https://doi.org/10.1124/mol.55.2.377

Q

  1. Qu, Xiaogang

    1. Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue
      Christian Bailly, Xiaogang Qu, Fabrice Anizon, Michelle Prudhomme, Jean-François Riou and Jonathan B. Chaires
      Molecular Pharmacology February 1999, 55 (2) 377-385; DOI: https://doi.org/10.1124/mol.55.2.377

R

  1. Raulf, Evelyn

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

  2. Regunathan, S.

    1. Inhibition of Astroglial Nitric Oxide Synthase Type 2 Expression by Idazoxan
      D. L. Feinstein, D. J. Reis and S. Regunathan
      Molecular Pharmacology February 1999, 55 (2) 304-308; DOI: https://doi.org/10.1124/mol.55.2.304

  3. Reis, D. J.

    1. Inhibition of Astroglial Nitric Oxide Synthase Type 2 Expression by Idazoxan
      D. L. Feinstein, D. J. Reis and S. Regunathan
      Molecular Pharmacology February 1999, 55 (2) 304-308; DOI: https://doi.org/10.1124/mol.55.2.304

  4. Ren, Hongzu

    1. Dexamethasone Stimulates Human A1 Adenosine Receptor (A1AR) Gene Expression through Multiple Regulatory Sites in Promoter B
      Hongzu Ren and Gary L. Stiles
      Molecular Pharmacology February 1999, 55 (2) 309-316; DOI: https://doi.org/10.1124/mol.55.2.309

  5. Riou, Jean-François

    1. Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue
      Christian Bailly, Xiaogang Qu, Fabrice Anizon, Michelle Prudhomme, Jean-François Riou and Jonathan B. Chaires
      Molecular Pharmacology February 1999, 55 (2) 377-385; DOI: https://doi.org/10.1124/mol.55.2.377

  6. Rosenberg, Robert L.

    1. Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids
      Jianyong Chen, Jorge H. Capdevila, Darryl C. Zeldin and Robert L. Rosenberg
      Molecular Pharmacology February 1999, 55 (2) 288-295; DOI: https://doi.org/10.1124/mol.55.2.288

  7. Rothlin, Carla V.

    1. The α9 Nicotinic Acetylcholine Receptor Shares Pharmacological Properties with Type A γ-Aminobutyric Acid, Glycine, and Type 3 Serotonin Receptors
      Carla V. Rothlin, Eleonora Katz, Miguel Verbitsky and A. Belén Elgoyhen
      Molecular Pharmacology February 1999, 55 (2) 248-254; DOI: https://doi.org/10.1124/mol.55.2.248

  8. Ryan, Stephen E.

    1. A Structure-Based Approach to Nicotinic Receptor Pharmacology
      Stephen E. Ryan and John E. Baenziger
      Molecular Pharmacology February 1999, 55 (2) 348-355; DOI: https://doi.org/10.1124/mol.55.2.348

S

  1. Scheer, Alexander

    1. Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
      Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
      Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339

  2. Schneider, Andrew J.

    1. Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
      David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
      Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332

  3. Schofield, Peter R.

    1. The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating
      Andrew J. Moorhouse, Patrice Jacques, Peter H. Barry and Peter R. Schofield
      Molecular Pharmacology February 1999, 55 (2) 386-395; DOI: https://doi.org/10.1124/mol.55.2.386

  4. Schröder, Helmut

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

  5. Schulz, Stefan

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

  6. Shen, Li

    1. Induction of p53-Dependent, Insulin-Like Growth Factor-Binding Protein-3-Mediated Apoptosis in Glioblastoma Multiforme Cells by a Protein Kinase Cα Antisense Oligonucleotide
      Li Shen, Nicholas M. Dean and Robert I. Glazer
      Molecular Pharmacology February 1999, 55 (2) 396-402; DOI: https://doi.org/10.1124/mol.55.2.396

  7. Silverstein, Roy L.

    1. Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
      David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
      Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332

  8. Stiles, Gary L.

    1. Dexamethasone Stimulates Human A1 Adenosine Receptor (A1AR) Gene Expression through Multiple Regulatory Sites in Promoter B
      Hongzu Ren and Gary L. Stiles
      Molecular Pharmacology February 1999, 55 (2) 309-316; DOI: https://doi.org/10.1124/mol.55.2.309

  9. Stokkeland, Knut

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  10. Strosberg, A. D.

    1. Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation
      C. C. Gerhardt, J. Gros, A. D. Strosberg and T. Issad
      Molecular Pharmacology February 1999, 55 (2) 255-262; DOI: https://doi.org/10.1124/mol.55.2.255

T

  1. Tanaka, Hideki

    1. Isolation of cDNAs Encoding Cellular Drug-Binding Proteins Using a Novel Expression Cloning Procedure: Drug-Western
      Hideki Tanaka, Nobuko Ohshima and Hiroyoshi Hidaka
      Molecular Pharmacology February 1999, 55 (2) 356-363; DOI: https://doi.org/10.1124/mol.55.2.356

  2. Tohkin, Masahiro

    1. A Novel Positive Regulatory Element That Enhances HamsterCYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element
      Kouichi Kurose, Masahiro Tohkin and Morio Fukuhara
      Molecular Pharmacology February 1999, 55 (2) 279-287; DOI: https://doi.org/10.1124/mol.55.2.279

V

  1. Verbitsky, Miguel

    1. The α9 Nicotinic Acetylcholine Receptor Shares Pharmacological Properties with Type A γ-Aminobutyric Acid, Glycine, and Type 3 Serotonin Receptors
      Carla V. Rothlin, Eleonora Katz, Miguel Verbitsky and A. Belén Elgoyhen
      Molecular Pharmacology February 1999, 55 (2) 248-254; DOI: https://doi.org/10.1124/mol.55.2.248

  2. Vincent, Jean-Pierre

    1. Pivotal Role of an Aspartate Residue in Sodium Sensitivity and Coupling to G Proteins of Neurotensin Receptors
      Stéphane Martin, Jean-Marie Botto, Jean-Pierre Vincent and Jean Mazella
      Molecular Pharmacology February 1999, 55 (2) 210-215; DOI: https://doi.org/10.1124/mol.55.2.210

  3. Volpert, Olga V.

    1. Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
      David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
      Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332

W

  1. Wang, Juan

    1. Characterization of a Bioengineered Chimeric Na+-Nucleoside Transporter
      Juan Wang and Kathleen M. Giacomini
      Molecular Pharmacology February 1999, 55 (2) 234-240; DOI: https://doi.org/10.1124/mol.55.2.234

  2. Wolf, Ronald

    1. Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
      Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
      Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263

X

  1. Xie, Yu

    1. The Steroid Promegestone Is a Noncompetitive Antagonist of theTorpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface
      Michael P. Blanton, Yu Xie, Lawrence J. Dangott and Jonathan. B. Cohen
      Molecular Pharmacology February 1999, 55 (2) 269-278; DOI: https://doi.org/10.1124/mol.55.2.269

  2. Xu, Lin

    1. Purine and Pyrimidine Nucleotides Inhibit a Noninactivating K+ Current and Depolarize Adrenal Cortical Cells through a G Protein-Coupled Receptor
      Lin Xu and John J. Enyeart
      Molecular Pharmacology February 1999, 55 (2) 364-376; DOI: https://doi.org/10.1124/mol.55.2.364

Z

  1. Zeldin, Darryl C.

    1. Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids
      Jianyong Chen, Jorge H. Capdevila, Darryl C. Zeldin and Robert L. Rosenberg
      Molecular Pharmacology February 1999, 55 (2) 288-295; DOI: https://doi.org/10.1124/mol.55.2.288

  2. Zhang-Gouillon, Zhi-Qi

    1. Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
      Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223

  3. Zhong, Hongying

    1. No Role for Ca++ or Protein Kinase C inAlpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells
      Alf Berts, Hongying Zhong and Kenneth P. Minneman
      Molecular Pharmacology February 1999, 55 (2) 296-303; DOI: https://doi.org/10.1124/mol.55.2.296
Back to top

In this issue